ArticleCommunications engineering2025
Democratizing high-Q plasmonic optical fiber biosensing with low-resolution interrogation and Fourier demodulation.
Article in Communications engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ultrahigh-figure-of-merit refractive-index sensing with grating-coupled magneto-optical hyperbolic metamaterials.Nanoscale advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Gold-coated tilted fiber Bragg gratings have established themselves as powerful plasmonic biosensors, but their widespread deployment remains hindered by the need for costly, high-resolution interrogators and complex signal processing. Here, we demonstrate that tilted fiber Bragg gratings sensors can be effectively interrogated using a low-cost, coarsely resolved fiber Bragg grating interrogator with only 256 pixels spanning 45 nm, corresponding to a low resolution (~180 pm, 10 times coarser than standard interrogators). By applying a fast Fourier transform-based demodulation technique to the dense, comb-like cladding mode spectrum, we extract robust sensing information using only a narrow spectral window of a few tens of nanometers. This dramatically reduces hardware and computational requirements while preserving high sensitivity. We validate our approach in both refractometry and biosensing, targeting the clinically relevant biomarker Proteinase 3. Furthermore, we show that temperature cross-sensitivity can be compensated directly within this narrow spectral range by tracking a dedicated cladding mode resonance, eliminating the need to reference the Bragg mode. These advances pave the way for compact, cost-effective, and user-friendly plasmonic fiber sensor systems deployable in real-world biomedical environments.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.